Progyny closed at $34.37 on Nov 5, up 14.19% — matching its 52-week closing high. Volume of 2.8M shares was 3.06× its 20-day average (well above normal).
Split-adjusted performance: +24.8% over one month, +79.4% over six months, +85.1% over one year.
In the quarter ended Jun 30, 2026, revenue was $350.51M, up 5.3% from a year earlier, with a net margin of 8.0%.
Short interest was 4.8M shares at the Oct 15 settlement, down 4.8% from the prior report (7.1% of float, 4.2 days to cover).